FDA Clears MagnetOs Putty for New Indication

December 10, 2018

The FDA granted 510(k) clearance to Kuros’ MagnetOs putty for use as a bone graft in the pelvis and extremities.

The putty is used to encourage progressive bone formation in patients. The product was previously cleared by the agency for use as an autograft extender in the posterolateral spine.

Kuros said the latest clearance paves the way for commercial expansion into new orthopedic applications such as reconstructive surgery.

View today's stories